Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
This randomized clinical trial studies different chemotherapies in treating patients with
myelodysplastic syndrome before donor stem cell transplant. Giving chemotherapy before a
donor stem cell transplant helps stop the growth of cancer cells in the bone marrow,
including normal blood-forming cells (stem cells) and cancer cells, and may prevent the
myelodysplastic syndrome from coming back after the transplant. When the healthy stem cells
from a donor are infused into the patient they may help the patient's bone marrow make stem
cells, red blood cells, white blood cells, and platelets.